Intrinsiqs

Is Unicycive Therapeutics, Inc. overvalued?

Unicycive Therapeutics, Inc. (UNCY) — key valuation metrics and fundamentals.

No verdict
Price
$4.64
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$123.9M
Dividend yield
0.0%
Return on equity
-88.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares UNCY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.